Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jan;93(1):33–39. doi: 10.1172/JCI116963

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.

E R Sher 1, D Y Leung 1, W Surs 1, J C Kam 1, G Zieg 1, A K Kamada 1, S J Szefler 1
PMCID: PMC293719  PMID: 8282803

Abstract

The current study examined whether alterations in glucocorticoid receptor (GR) binding contribute to poor response to glucocorticoid therapy in asthma. 29 asthma patients with forced expiratory volume in 1 s (FEV1) < 70% predicted were studied. Patients were classified as steroid sensitive (SS) if their morning FEV1 increased > 30% after a 1-wk course of oral prednisone 20 mg twice daily and steroid resistant (SR) if they failed to increase > 15%. PBMC obtained from these two groups, 17 SR and 12 SS, as well as 12 normal controls were analyzed. SR patients had two distinguishable GR binding abnormalities: 15 of the 17 SR patients demonstrated a significantly reduced GR binding affinity, as compared with SS patients (P = 0.0001) and normal controls (P = 0.0001). This defect was localized to T cells and reverted to normal after 48 h in culture media. However, incubation with a combination of IL-2 and IL-4 sustained this abnormality. The other two SR patients had an abnormally low GR number with normal binding affinity that was not limited to T cells. Furthermore, GR number failed to normalize after incubation in media alone or IL-2 and IL-4. Therefore, SR asthma may be due to more than one abnormality, the majority related to a reversible cytokine-induced reduction in GR binding affinity and the second related to an irreversible reduction in GR number. These findings may have important implications for the design of alternative treatment approaches for recalcitrant asthma.

Full text

PDF
33

Images in this article

35Image
on p.35
37Image
on p.37
37Image
on p.37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez J., Surs W., Leung D. Y., Iklé D., Gelfand E. W., Szefler S. J. Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol. 1992 Mar;89(3):714–721. doi: 10.1016/0091-6749(92)90379-g. [DOI] [PubMed] [Google Scholar]
  2. Carmichael J., Paterson I. C., Diaz P., Crompton G. K., Kay A. B., Grant I. W. Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) 1981 May 2;282(6274):1419–1422. doi: 10.1136/bmj.282.6274.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chrousos G. P., Vingerhoeds A., Brandon D., Eil C., Pugeat M., DeVroede M., Loriaux D. L., Lipsett M. B. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest. 1982 Jun;69(6):1261–1269. doi: 10.1172/JCI110565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corrigan C. J., Brown P. H., Barnes N. C., Szefler S. J., Tsai J. J., Frew A. J., Kay A. B. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis. 1991 Nov;144(5):1016–1025. doi: 10.1164/ajrccm/144.5.1016. [DOI] [PubMed] [Google Scholar]
  5. Corrigan C. J., Brown P. H., Barnes N. C., Tsai J. J., Frew A. J., Kay A. B. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis. 1991 Nov;144(5):1026–1032. doi: 10.1164/ajrccm/144.5.page. [DOI] [PubMed] [Google Scholar]
  6. Diamond M. I., Miner J. N., Yoshinaga S. K., Yamamoto K. R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 1990 Sep 14;249(4974):1266–1272. doi: 10.1126/science.2119054. [DOI] [PubMed] [Google Scholar]
  7. Gustafsson J. A., Carlstedt-Duke J., Poellinger L., Okret S., Wikström A. C., Brönnegård M., Gillner M., Dong Y., Fuxe K., Cintra A. Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev. 1987 May;8(2):185–234. doi: 10.1210/edrv-8-2-185. [DOI] [PubMed] [Google Scholar]
  8. Herrscher R. F., Kasper C., Sullivan T. J. Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions. J Clin Invest. 1992 Aug;90(2):596–603. doi: 10.1172/JCI115898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hill M. R., Szefler S. J., Ball B. D., Bartoszek M., Brenner A. M. Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther. 1990 Oct;48(4):390–398. doi: 10.1038/clpt.1990.167. [DOI] [PubMed] [Google Scholar]
  10. Hurley D. M., Accili D., Stratakis C. A., Karl M., Vamvakopoulos N., Rorer E., Constantine K., Taylor S. I., Chrousos G. P. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest. 1991 Feb;87(2):680–686. doi: 10.1172/JCI115046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jain J., McCaffrey P. G., Valge-Archer V. E., Rao A. Nuclear factor of activated T cells contains Fos and Jun. Nature. 1992 Apr 30;356(6372):801–804. doi: 10.1038/356801a0. [DOI] [PubMed] [Google Scholar]
  12. Kamada A. K., Leung D. Y., Gleason M. C., Hill M. R., Szefler S. J. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. J Allergy Clin Immunol. 1992 Oct;90(4 Pt 1):685–687. doi: 10.1016/0091-6749(92)90144-q. [DOI] [PubMed] [Google Scholar]
  13. Kamada A. K., Leung D. Y., Szefler S. J. Steroid resistance in asthma: our current understanding. Pediatr Pulmonol. 1992 Nov;14(3):180–186. doi: 10.1002/ppul.1950140307. [DOI] [PubMed] [Google Scholar]
  14. Law C. M., Marchant J. L., Honour J. W., Preece M. A., Warner J. O. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet. 1986 Apr 26;1(8487):942–944. doi: 10.1016/s0140-6736(86)91045-7. [DOI] [PubMed] [Google Scholar]
  15. Munck A., Mendel D. B., Smith L. I., Orti E. Glucocorticoid receptors and actions. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S2–10. [PubMed] [Google Scholar]
  16. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992 Jan 30;326(5):298–304. doi: 10.1056/NEJM199201303260504. [DOI] [PubMed] [Google Scholar]
  17. Schwartz H. J., Lowell F. C., Melby J. C. Steroid resistance in bronchial asthma. Ann Intern Med. 1968 Sep;69(3):493–499. doi: 10.7326/0003-4819-69-3-493. [DOI] [PubMed] [Google Scholar]
  18. Szefler S. J. Anti-inflammatory drugs in the treatment of allergic disease. Med Clin North Am. 1992 Jul;76(4):953–975. doi: 10.1016/s0025-7125(16)30334-0. [DOI] [PubMed] [Google Scholar]
  19. Szefler S. J. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol. 1991 Aug;88(2):147–165. doi: 10.1016/0091-6749(91)90323-g. [DOI] [PubMed] [Google Scholar]
  20. Tabachnik E., Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatr. 1991 Feb;118(2):294–297. doi: 10.1016/s0022-3476(05)80506-2. [DOI] [PubMed] [Google Scholar]
  21. Walker C., Bode E., Boer L., Hansel T. T., Blaser K., Virchow J. C., Jr Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992 Jul;146(1):109–115. doi: 10.1164/ajrccm/146.1.109. [DOI] [PubMed] [Google Scholar]
  22. Wilson J. W., Djukanović R., Howarth P. H., Holgate S. T. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):958–960. doi: 10.1164/ajrccm/145.4_Pt_1.958. [DOI] [PubMed] [Google Scholar]
  23. Yang-Yen H. F., Chambard J. C., Sun Y. L., Smeal T., Schmidt T. J., Drouin J., Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 1990 Sep 21;62(6):1205–1215. doi: 10.1016/0092-8674(90)90396-v. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES